Free Trial

Profound Medical (PROF) Competitors

Profound Medical logo
$5.50 +0.19 (+3.58%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$5.48 -0.01 (-0.27%)
As of 10/24/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROF vs. SIBN, BFLY, BVS, ZIMV, AVNS, CBLL, KIDS, SMLR, TMCI, and DCTH

Should you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include SiBone (SIBN), Butterfly Network (BFLY), Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), CeriBell (CBLL), OrthoPediatrics (KIDS), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.

Profound Medical vs. Its Competitors

Profound Medical (NASDAQ:PROF) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

47.9% of Profound Medical shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 1.5% of Profound Medical shares are held by insiders. Comparatively, 4.0% of SiBone shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profound Medical currently has a consensus price target of $11.00, indicating a potential upside of 100.00%. SiBone has a consensus price target of $23.00, indicating a potential upside of 48.48%. Given Profound Medical's higher probable upside, equities research analysts clearly believe Profound Medical is more favorable than SiBone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Profound Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
SiBone
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

SiBone has a net margin of -12.83% compared to Profound Medical's net margin of -343.97%. SiBone's return on equity of -14.20% beat Profound Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Profound Medical-343.97% -89.74% -73.06%
SiBone -12.83%-14.20%-10.38%

Profound Medical has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, SiBone has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500.

In the previous week, SiBone had 1 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for SiBone and 1 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.95 equaled SiBone'saverage media sentiment score.

Company Overall Sentiment
Profound Medical Positive
SiBone Positive

Profound Medical has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Profound Medical$10.68M15.55-$27.82M-$1.46-3.77
SiBone$185.26M3.61-$30.91M-$0.56-27.66

Summary

SiBone beats Profound Medical on 11 of the 15 factors compared between the two stocks.

Get Profound Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PROF vs. The Competition

MetricProfound MedicalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$160.21M$2.97B$6.24B$10.65B
Dividend YieldN/A57.75%5.71%4.82%
P/E Ratio-3.7726.3230.6130.44
Price / Sales15.55782.63596.73191.77
Price / CashN/A168.3237.0161.44
Price / Book2.745.6512.036.60
Net Income-$27.82M$33.06M$3.32B$276.82M
7 Day Performance-0.54%3.16%1.89%2.55%
1 Month Performance7.42%8.14%7.71%3.76%
1 Year Performance-24.76%-2.49%56.33%33.04%

Profound Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PROF
Profound Medical
1.5591 of 5 stars
$5.50
+3.6%
$11.00
+100.0%
-23.7%$160.21M$10.68M-3.77150
SIBN
SiBone
3.6991 of 5 stars
$14.94
+1.1%
$23.67
+58.4%
+22.8%$637.62M$167.18M-26.68350
BFLY
Butterfly Network
2.656 of 5 stars
$2.30
+0.7%
$3.00
+30.7%
+26.4%$573.97M$82.06M-8.20460Analyst Forecast
Gap Up
BVS
Bioventus
0.8707 of 5 stars
$6.57
+0.9%
N/AN/A$538.24M$573.28M13.021,200News Coverage
Analyst Forecast
ZIMV
ZimVie
0.6177 of 5 stars
$18.97
+0.1%
$17.75
-6.4%
+34.2%$534.88M$449.75M-27.101,770Upcoming Earnings
AVNS
AVANOS MEDICAL
2.4939 of 5 stars
$10.86
+1.5%
N/A-46.9%$496.51M$687.80M-1.082,227News Coverage
Upcoming Earnings
CBLL
CeriBell
2.505 of 5 stars
$11.98
+0.3%
$32.14
+168.3%
N/A$438.13M$65.44M-4.01N/ANews Coverage
Analyst Forecast
KIDS
OrthoPediatrics
4.5089 of 5 stars
$17.51
+7.4%
$26.29
+50.1%
-33.5%$408.70M$204.73M-9.78200Upcoming Earnings
SMLR
Semler Scientific
3.5242 of 5 stars
$26.33
-1.8%
$74.25
+182.0%
-13.4%$405.81M$56.29M10.84120Trending News
TMCI
Treace Medical Concepts
2.1473 of 5 stars
$6.00
+2.0%
$9.83
+63.9%
+39.4%$371.46M$209.36M-7.59250News Coverage
Analyst Forecast
DCTH
Delcath Systems
2.7087 of 5 stars
$11.35
+8.5%
$24.50
+115.9%
-3.9%$365.90M$37.21M227.0060News Coverage
Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NASDAQ:PROF) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners